Document Detail


Reduction in the response to coronary and iliac artery injury with photodynamic therapy using 5-aminolaevulinic acid.
MedLine Citation:
PMID:  10728369     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Photodynamic therapy (PDT) uses red light (non-thermal, non-ionising) to activate a previously administered photosensitizing drug. This inhibits neointimal hyperplasia in injured arteries in small animals where it appears safe and well tolerated. Our aim was to develop a method for percutaneous application of PDT to iliac and coronary arteries in a large animal model and investigate its influence on the remodeling and intimal hyperplastic response to balloon injury. METHODS: Studies were undertaken on 13 juvenile Large White-Landrace crossbred pigs (15-20 kg). After intravenous administration of the photosensitizing agent 5-amino laevulinic acid (ALA), the arterial tree was accessed via the left common carotid artery and balloon injuries made by over-distension in both common iliacs (thirteen animals) and one or two main coronary arteries (eight animals). Half the injured sites were then illuminated with red laser light transmitted via the catheter. Animals were culled 28 days later and tissue harvested for histomorphometry. RESULTS: Compared with control injured vessels, PDT treated, balloon injured coronary arteries had a larger lumen (1.4 vs. 0.8 mm2, P = 0.002), larger area within the external elastic lamina (2.8 vs. 2.2 mm2, P = 0.006) and smaller area of neointimal hyperplasia (0.4 vs. 0.7 mm2, P = 0.06), 28 days after intervention. Less neointimal hyperplasia and the absence of negative remodeling resulted in the lumen of PDT-treated, injured segments being the same as that of adjacent reference segments (1.5 vs. 1.6 mm2). Similar trends, but with smaller differences, were seen in the iliac vessels. CONCLUSIONS: Intra-arterial, trans-catheter PDT favourably influences the arterial response to balloon injury in both the coronary and peripheral circulations. This technique offers a promising new approach to restenosis after endovascular procedures.
Authors:
M P Jenkins; G A Buonaccorsi; R Mansfield; C C Bishop; S G Bown; J R McEwan
Related Documents :
2146039 - Iliofemoral arterial complications of balloon angioplasty for systemic obstructions in ...
11779019 - Temporary percutaneous aortic balloon occlusion to enhance fluid resuscitation prior to...
17125639 - Alpha(2)-blocker helps to avoid systemic to pulmonary shunt in a prostaglandin dependen...
2672399 - Mechanisms and prevention of arterial injuries caused by balloon embolectomy.
3286139 - The treatment of endobronchial stenosis using balloon catheter dilatation.
6396309 - Percutaneous treatment of small bowel obstruction due to a gastrostomy tube.
12607649 - Sequential diagnosis of coronary arterial anatomy in congenitally corrected transpositi...
21367559 - Staged hybrid repair using telescoped stent graft fixation for aortic arch and descendi...
916719 - Method for resection and prosthetic replacement of aneurysm of aortic arch.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cardiovascular research     Volume:  45     ISSN:  0008-6363     ISO Abbreviation:  Cardiovasc. Res.     Publication Date:  2000 Jan 
Date Detail:
Created Date:  2000-04-11     Completed Date:  2000-04-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0077427     Medline TA:  Cardiovasc Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  478-85     Citation Subset:  IM    
Affiliation:
Department of Surgery, Royal Free and University College Medical School, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aminolevulinic Acid / therapeutic use*
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects*
Animals
Coronary Disease / prevention & control
Coronary Vessels / drug effects,  injuries*,  pathology
Iliac Artery / drug effects,  injuries*,  pathology
Photochemotherapy*
Photosensitizing Agents / therapeutic use*
Swine
Chemical
Reg. No./Substance:
0/Photosensitizing Agents; 106-60-5/Aminolevulinic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endothelin-dependent effects limit flow-induced dilation of conductance coronary vessels after block...
Next Document:  Shear stress induces angiotensin converting enzyme expression in cultured smooth muscle cells: possi...